Atossa Therapeutics progresses Phase II preventative breast cancer therapy

Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans a Phase III preventative breast cancer trial.

Jan 27, 2024 - 18:00

Atossa Therapeutics progresses Phase II preventative breast cancer therapy

Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans a Phase III preventative breast cancer trial.

Read the original article

Tags:

Previous Article

CAR-T therapies and cancer risk: No easy answers for the FDA

FDA expands approval of Dupixent for eosinophilic esophagitis in children

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

New chronic Covid study offers insight into which immunocompromised patients are most at risk

New chronic Covid study offers insight into which immun...

Jan 24, 2024

Codiak BioSciences gets grant for extracellular vesicle...

Aug 23, 2024

Putting radiation to the test to heal irregular heartbeat

Putting radiation to the test to heal irregular heartbeat

Apr 29, 2023